Concepedia

Tobias R. Overbeck

TR

25

Publications

3.3K

Citations

18

H-Index

2001

Active since

Affiliations

Universitätsmedizin Göttingen(Current)

University of Göttingen

Heidelberg University

University Hospital Heidelberg

Charité - Universitätsmedizin Berlin

Tobias R. Overbeck is an author at Universitätsmedizin Göttingen specializing in medicine, oncology, and cancer therapeutics.

ORCID

Top concepts

Publications per year

2001–2024

25

Publications

25

Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials

Robert C. Doebele, Alexander Drilon, Luis Paz‐Ares et al. · The Lancet Oncology · 2019 · 1.7K citations · Full text

Capmatinib in <i>MET</i> Exon 14–Mutated or <i>MET</i> -Amplified Non–Small-Cell Lung Cancer

Jürgen Wolf, Takashi Seto, Ji‐Youn Han et al. · New England Journal of Medicine · 2020 · 957 citations · Full text

Detection of pulmonary nodules at spiral CT: comparison of maximum intensity projection sliding slabs and single-image reporting

Stefan Diederich, Markus Lentschig, Tobias R. Overbeck et al. · European Radiology · 2001 · 61 citations

, , +13

Toxicity of daily low dose cisplatin in radiochemotherapy for locally advanced head and neck cancer

Hendrik A. Wolff, Tobias R. Overbeck, Ralph M.W. Roedel et al. · Journal of Cancer Research and Clinical Oncology · 2008 · 60 citations · Full text

Talactoferrin alfa versus placebo in patients with refractory advanced non-small-cell lung cancer (FORTIS-M trial)

Suresh S. Ramalingam, Jeffrey Crawford, Alex Y. Chang et al. · Annals of Oncology · 2013 · 55 citations

, , +9

Rows per page

1–5 of 25